Dr. Sulaiman Al Habib Medical Services Group revenue and financials
SAR 228.90Change from previous close: +0.18%Absolute change: +SAR 0.40
In the fiscal year ended December 2025, Dr. Sulaiman Al Habib Medical Services Group reported revenue of SAR 13.71B (+22.38% year over year). Net income was SAR 2.4B, a net margin of 17.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +22.38%
- 2025 vs 2024
- Net income growth
- +3.72%
- 2025 vs 2024
- Net margin
- 17.5%
- 2024: 20.7%
Financial data
Amounts in millions of SAR; per-share values in SAR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 13,707 | 11,200 | 9,508 | 8,311 | 7,250 |
| Cost of revenue | 9,513 | 7,471 | 6,255 | 5,578 | 4,934 |
| Gross profit | 4,194 | 3,730 | 3,254 | 2,733 | 2,316 |
| Selling, general and administrative | 1,575 | 1,373 | 1,158 | 1,032 | 850 |
| Operating income | 2,619 | 2,356 | 2,096 | 1,700 | 1,466 |
| EBIT | 2,619 | 2,356 | 2,096 | 1,700 | 1,466 |
| EBITDA | 3,193 | 2,711 | 2,358 | 1,960 | 1,728 |
| Interest expense | 339 | 163 | 70.1 | 49.4 | 37.9 |
| Pre-tax income | 2,519 | 2,413 | 2,170 | 1,797 | 1,501 |
| Income tax | 27.6 | 42.9 | 68.5 | 108 | 114 |
| Net income | 2,401 | 2,315 | 2,046 | 1,651 | 1,377 |
| Net income to common shareholders | 2,401 | 2,315 | 2,046 | 1,651 | 1,377 |
| Basic EPS | 6.86 | 6.62 | 5.85 | 4.72 | 3.93 |
| Diluted EPS | 6.86 | 6.62 | 5.85 | 4.72 | 3.93 |
| Average shares (basic) | 350 | 350 | 350 | 350 | 350 |
| Average shares (diluted) | 350 | 350 | 350 | 350 | 350 |
| Dividend per share | 4.83 | 4.77 | 4.32 | 3.48 | 2.80 |